Gelsyn-3 Injection Cost: What You'll Pay in 2026 (Medicare & Self-Pay)
Gelsyn-3 costs $300–$900 self-pay for the full 3-injection course. Medicare Part B patients pay roughly $80–$130 total. 2026 pricing, J7328 billing, and tips to cut your costs.
By Joint Pain Authority Team
Key Takeaways
- Gelsyn-3 self-pay costs approximately $300–$900 total for the complete 3-injection course — medication costs only; add office visit fees on top
- With Medicare Part B, patients typically pay $80–$130 total for the full 3-injection course (20% coinsurance after deductible is met)
- Gelsyn-3 is billed under HCPCS code J7328 (per 0.1 mg sodium hyaluronate) — one 30 mg syringe equals 300 units per injection
- Gelsyn-3 is non-avian, derived from bacterial fermentation — it is safe for patients with bird or egg allergies
- The injection procedure itself is billed under CPT 20610 or 20611 (arthrocentesis, major joint) — separate from the drug charge
- Gelsyn-3’s US distribution is handled by Bioventus (manufactured by IBSA Farmaceutici) — patients may qualify for manufacturer support programs
- Discount programs can meaningfully reduce self-pay costs; ask your provider about cash-pay rates before your appointment
Gelsyn-3 is a 3-injection hyaluronic acid treatment for knee osteoarthritis that spreads relief across three weekly visits. If your doctor has recommended Gelsyn-3, knowing exactly what it costs — with Medicare, without insurance, and relative to alternatives — helps you plan ahead and avoid billing surprises.
This guide covers 2026 pricing for all scenarios: Medicare Part B, private insurance, and self-pay, plus strategies to minimize your out-of-pocket costs.
What Is Gelsyn-3 and Why It Costs What It Does
Gelsyn-3 is a sodium hyaluronate injection manufactured by IBSA Farmaceutici and distributed in the United States by Bioventus. It is administered as a series of three weekly intra-articular injections into the affected knee, each delivering 30 mg of sodium hyaluronate in a 3 mL syringe.
A key differentiator for many patients: Gelsyn-3 is non-avian. The hyaluronic acid is produced through bacterial fermentation rather than rooster comb extraction. This matters clinically and financially for several reasons:
- Allergy safety: Because it contains no avian-derived material, Gelsyn-3 is one of the few hyaluronic acid injection options that is safe for patients with bird or egg allergies. The avian-derived alternatives (Hyalgan, Synvisc-One, Supartz FX, Gel-One) carry a contraindication for these patients.
- Manufacturing process: Bacterial fermentation requires specialized pharmaceutical infrastructure — this contributes to production costs but also ensures a highly purified, consistent product free of avian proteins.
- Intermediate price tier: Gelsyn-3 sits in the mid-price range — more affordable than premium single-injection brands and roughly comparable to other 3-injection series brands on a per-course basis.
The cost of Gelsyn-3 at your appointment reflects multiple layers: the drug’s wholesale acquisition cost, provider markup, facility type, and any separately billed services such as imaging guidance for injection placement.
Gelsyn-3 Cost Without Insurance (Self-Pay)
Self-Pay Price Ranges for Gelsyn-3 (2026)
| Cost Component | Estimated Range |
|---|---|
| Gelsyn-3 per injection (medication only) | $100–$300 per syringe |
| 3-injection course (medication total) | $300–$900 |
| Office visit fee per injection | $50–$200 |
| Imaging guidance (ultrasound/fluoroscopy) | $100–$300 per visit |
| Total self-pay for full 3-injection course | $550–$1,800+ |
Sources: MDsave (procedure price transparency data, 2025–2026); provider self-pay quotes vary by region. Ranges reflect office-based clinic pricing; hospital outpatient departments typically cost more.
Self-pay pricing for Gelsyn-3 is generally more favorable than single-injection premium brands, but the full cost of three office visits adds up quickly. The medication cost alone is only part of the picture — see the Hidden Costs section below for the full accounting.
Why Prices Vary So Much
Gelsyn-3 pricing varies significantly across providers and regions for several reasons:
- Provider markup over wholesale: Clinics purchase Gelsyn-3 at wholesale and mark up the price when billing patients. Office-based orthopedic and pain-management practices typically charge considerably less than hospital outpatient departments for the same product.
- Geographic variation: High cost-of-living markets such as New York, San Francisco, and Chicago tend to carry higher procedure fees for equivalent services.
- Bundled vs. unbundled pricing: Some providers quote an all-in price for each visit; others bill the drug, the injection procedure, and imaging guidance as three separate line items. Always ask what is included in the quoted price.
- Cash-pay vs. list price: Many providers offer a reduced self-pay rate for patients paying out of pocket at the time of service — these are often 20–40% below the “retail” billed amount. Ask explicitly for the self-pay or cash-pay price.
- Discount card pricing: Prescription discount programs (SingleCare, GoodRx, RxSaver) may further reduce the medication cost at participating pharmacies, though coverage of injectables administered in-office varies by program.
Tip: Call providers in advance and ask, “What is your self-pay price for a Gelsyn-3 injection, and is imaging guidance included?” A 10-minute phone call before scheduling can save hundreds of dollars.
Gelsyn-3 Cost With Medicare Part B
Medicare Coverage for Gelsyn-3
Coverage status: Yes — Medicare Part B covers Gelsyn-3 (J7328) when medically necessary for knee osteoarthritis
Typical patient cost with Medicare (full 3-injection course):
- Annual Part B deductible: $257 (2025 figure; verify the current year’s deductible with Medicare.gov)
- After deductible is met: You pay 20% coinsurance of the Medicare-approved amount per injection
- Medicare pays 80% of the approved amount
Estimated patient out-of-pocket per injection (deductible already met):
- Drug (J7328): approximately $27–$36 (20% of ~$135–$180 Medicare-approved amount)
- Injection procedure (20610/20611): approximately $10–$25 (20% of provider’s allowed amount)
- Total per visit: roughly $37–$61
Estimated total out-of-pocket for 3-injection course (deductible met): approximately $80–$130
Source: CMS Average Sales Price (ASP) Drug Pricing Files for J7328; Medicare Physician Fee Schedule for CPT 20610/20611 (rates vary by location). ASP rates are updated quarterly; verify at cms.gov/medicare/payment/part-b-drugs/drug-pricing-downloads.
How Medicare Bills Gelsyn-3
Medicare classifies Gelsyn-3 under HCPCS code J7328 — “Hyaluronan or derivative, Gelsyn-3, for intra-articular injection, 0.1 mg” — meaning the code is billed per 0.1 mg (10 units per 1 mg). Each Gelsyn-3 syringe delivers 30 mg of sodium hyaluronate, so providers bill 300 units of J7328 per injection.
Medicare’s payment rate is based on the Average Sales Price (ASP) plus 6%, updated quarterly by CMS. The ASP for J7328 has ranged from approximately $0.45–$0.60 per unit (0.1 mg) in recent quarters, placing the Medicare-approved drug amount per injection at roughly $135–$180.
The injection administration itself is billed separately under CPT 20610 (arthrocentesis of a major joint without image guidance) or CPT 20611 (with ultrasound guidance). Medicare’s allowable for 20610 is approximately $45–$55 in most localities; 20611 is typically $65–$90. Your 20% share of the procedure fee is thus roughly $9–$18 per visit.
Note on ASP Timing: CMS updates J7328 ASP rates each quarter (January, April, July, October). The figures above reflect recent published rates; check the current quarter’s ASP pricing file at cms.gov for the most precise numbers before your procedure.
Medicare Coverage Requirements
Medicare covers Gelsyn-3 under its viscosupplementation benefit when the following criteria are documented in your medical record:
Medicare does not require a specific number of failed prior conservative treatments to be documented — but your provider must include clinical notes supporting medical necessity. Well-documented records reduce the risk of a post-service claim denial.
Medicare Advantage Plans
If you are enrolled in a Medicare Advantage (Part C) plan rather than Original Medicare, your Gelsyn-3 coverage may differ:
- Some Medicare Advantage plans require prior authorization before any viscosupplementation injection
- Plans may have a preferred brand list — check whether Gelsyn-3 is preferred or if a non-preferred brand requires a higher cost-share
- Network restrictions may limit which providers can administer the injection at the in-network benefit level
- Some plans impose a step therapy requirement, specifying that corticosteroid injections must be tried first
Always call your Medicare Advantage plan to verify Gelsyn-3 coverage and get prior authorization before scheduling. The number on your plan card connects you to a benefits specialist who can tell you your exact cost-share.
Gelsyn-3 Cost With Private Insurance
Most commercial health insurance plans cover Gelsyn-3 (and viscosupplementation broadly) when medical necessity criteria are satisfied — typically the same conservative-treatment-failure requirements Medicare uses.
Typical private insurance process for Gelsyn-3:
- Prior authorization is almost universally required — submit through your provider’s office before scheduling
- Step therapy: Your plan may require documented failure of physical therapy, NSAIDs, and/or corticosteroid injections before approving viscosupplementation
- Formulary tier: Some plans designate specific HA brands as preferred; Gelsyn-3 may or may not be on your plan’s preferred list — non-preferred brands typically carry higher coinsurance
- Copay or coinsurance per injection: Typically $30–$150 per visit depending on your plan’s specialist copay or coinsurance rate
- Deductible: If you have not met your annual deductible, you pay the full plan-allowed amount for each injection until the deductible is satisfied
Tip: Ask your provider’s office to contact your insurance company before your first injection appointment. A good clinic handles prior authorization proactively and will let you know if there are any issues before you arrive.
Gelsyn-3 vs. Other Multi-Injection Series Brands: Cost Comparison
Gelsyn-3 is one of several FDA-approved multi-injection hyaluronic acid products. Understanding how its cost compares to alternatives helps you have an informed conversation with your doctor about which brand is the best fit for your situation and budget.
| Brand | Injections | Source | Self-Pay (Full Course) | Medicare Coverage | Bird/Egg Safe |
|---|---|---|---|---|---|
| Gelsyn-3 | 3 | Non-avian (bacterial) | $300–$900 | Yes (J7328) | Yes |
| Euflexxa | 3 | Non-avian (bacterial) | $600–$1,200 | Yes (J7323) | Yes |
| Orthovisc | 3–4 | Non-avian (bacterial) | $400–$1,000 | Yes (J7324) | Yes |
| Hyalgan | 3–5 | Avian (rooster comb) | $500–$900 | Yes (J7321) | No |
| Supartz FX | 3–5 | Avian (rooster comb) | $500–$1,000 | Yes (J7321) | No |
Sources: MDsave procedure pricing; CMS Medicare Physician Fee Schedule and HCPCS code references; manufacturer prescribing information for allergy status. Self-pay figures are representative ranges and will vary by provider and region.
Key takeaway for cost-comparison shopping: Gelsyn-3 tends to have one of the more competitive self-pay prices among 3-injection non-avian brands. For patients who need to avoid avian-derived products, Gelsyn-3, Euflexxa, and Orthovisc are all viable options — Gelsyn-3 often comes in at a lower per-course cost than Euflexxa at comparable providers.
Gelsyn-3 vs. Single-Injection Brands: True Cost Comparison
Single-injection brands like Synvisc-One, Monovisc, Durolane, and Gel-One may appear more expensive per dose, but comparing total costs across the full treatment cycle — including office visits — tells a more complete story.
| Gelsyn-3 (3 injections) | Synvisc-One (single) | Monovisc (single) | Durolane (single) | |
|---|---|---|---|---|
| Injections needed | 3 | 1 | 1 | 1 |
| Office visits | 3 | 1 | 1 | 1 |
| Medication cost (self-pay) | $300–$900 total | $600–$1,200 | $500–$1,000 | $300–$1,465 |
| Office visit copays | 3× | 1× | 1× | 1× |
| Time commitment | 3 weekly visits | 1 visit | 1 visit | 1 visit |
| Avian-free | Yes | No (avian) | Yes | Yes |
The offset calculation: Each additional office visit carries its own copay or coinsurance. For a Medicare patient with a $20 copay per specialist visit, Gelsyn-3 adds $40 more in visit costs compared to a single-injection brand — but if Gelsyn-3’s medication cost is $200–$600 lower per course, the math can still favor Gelsyn-3.
For patients who prefer fewer clinic visits or who have high per-visit copays, a single-injection brand may ultimately cost less in total. Discuss the tradeoff with your provider in the context of your specific plan and schedule.
Hidden Costs to Budget For
When planning for Gelsyn-3, account for these frequently overlooked expenses beyond the drug charge itself:
Costs Patients Often Miss
Office/consultation visit fee: Each of the three injection appointments may carry a separate office visit fee ($50–$200 per visit). Some providers bundle this; others bill it separately.
Imaging guidance fee: Ultrasound or fluoroscopy guidance improves injection accuracy and is commonly used. If billed separately (CPT 76942 for ultrasound or 77002 for fluoroscopy), expect $100–$300 per visit without insurance. Medicare covers ultrasound guidance when medically indicated.
Pre-injection knee X-ray: If you have not recently had knee imaging, your provider may order X-rays to confirm the diagnosis before starting treatment ($100–$300 self-pay).
Facility fees: If your injections are performed in a hospital outpatient department rather than an office-based clinic, an additional facility fee of $200–$500+ per visit may be charged on top of the injection and drug fees. Choose office-based clinics when possible to avoid this cost layer.
Follow-up assessment: Many providers schedule a visit 4–6 weeks after your final injection to assess your response. This visit carries its own copay or office fee.
Transportation and time: Three weekly appointments mean three trips to the clinic. Factor travel time and costs (parking, rides) into your planning — especially for patients with limited mobility or transportation access.
How to Reduce Your Out-of-Pocket Costs
For Medicare Patients
For Self-Pay and Underinsured Patients
Frequently Asked Questions
Does Medicare cover Gelsyn-3 injections?
Yes. Medicare Part B covers Gelsyn-3 (billed under HCPCS J7328) for knee osteoarthritis when the treatment is deemed medically necessary and conservative treatments have been tried without adequate relief. After meeting your annual Part B deductible ($257 in 2025), you pay 20% coinsurance on the Medicare-approved amount. For the full 3-injection course, most Medicare patients pay approximately $80–$130 total in drug coinsurance, plus a separate 20% share for each injection procedure fee.
How much does Gelsyn-3 cost without insurance?
Without insurance, Gelsyn-3 costs approximately $100–$300 per injection for the medication alone, or $300–$900 for the complete 3-injection course. Adding office visit fees and imaging guidance typically brings the all-in cost to $550–$1,800+ for the full course. Exact pricing depends heavily on your provider, geographic location, and whether you negotiate a cash-pay rate. Always ask for the self-pay price before scheduling — many providers offer significant discounts for cash-paying patients.
What HCPCS and CPT codes are used for Gelsyn-3?
Gelsyn-3 is billed under HCPCS code J7328 for the drug itself — specifically, “Hyaluronan or derivative, Gelsyn-3, for intra-articular injection, 0.1 mg per unit.” One 30 mg syringe = 300 units of J7328 billed per injection appointment. The injection procedure is billed separately under CPT 20610 (arthrocentesis, major joint, without imaging guidance) or CPT 20611 (with ultrasound guidance and permanent recording and reporting). When verifying coverage or preparing for a prior authorization request, having these codes in hand helps you or your provider confirm benefit status quickly with your insurance.
Is Gelsyn-3 safe for patients with bird or egg allergies?
Yes. Gelsyn-3 is non-avian — its sodium hyaluronate is produced through bacterial fermentation rather than extracted from rooster combs or other avian sources. It contains no avian-derived proteins and is therefore safe for patients with bird or egg allergies. By contrast, Hyalgan, Synvisc-One, Supartz FX, and Gel-One are derived from avian sources and carry a contraindication for patients with known bird or poultry product allergies. If you have such an allergy, confirm your provider is aware so they can select an appropriate non-avian brand.
Who manufactures and distributes Gelsyn-3 in the US?
Gelsyn-3 is manufactured by IBSA Farmaceutici, an Italian pharmaceutical company, and distributed in the United States by Bioventus (Durham, NC). When looking for patient support programs, financial assistance, or prescribing information, contact Bioventus — they are the US commercial entity for Gelsyn-3 and other HA products. Do not confuse Gelsyn-3 with brands distributed by Mylan or other pharmaceutical companies.
How does Gelsyn-3 compare in cost to Euflexxa or Orthovisc?
All three are non-avian, 3-injection hyaluronic acid products — and all three are Medicare-covered. On a per-course basis, Gelsyn-3 tends to be priced similarly to or slightly below Euflexxa and Orthovisc at many providers, though pricing varies by location and provider relationship with the manufacturer. Medicare reimbursement differs slightly by brand based on current ASP rates; your 20% coinsurance will reflect the specific Medicare-approved amount for whichever brand your provider orders. Discuss brand selection with your provider based on clinical preference, formulary status, and your insurer’s coverage policies.
How often can I get Gelsyn-3 and what does that mean for annual costs?
Medicare’s policy allows repeat viscosupplementation treatment no sooner than 6 months after a prior course when the prior course was effective. If you receive two 3-injection courses per year — the maximum under Medicare — your annual drug coinsurance (with deductible met) would be approximately $160–$260 for the medication, plus procedure fees. Self-pay patients would pay $600–$1,800 or more annually for twice-yearly treatment. For many patients, relief from a single course lasts 6–12 months, making annual costs highly individual.
Is prior authorization required for Gelsyn-3?
For Medicare Original (Parts A and B), prior authorization is generally not required — coverage is determined by medical necessity documentation in your chart. However, many Medicare Advantage plans and most private insurance plans do require prior authorization for viscosupplementation. Your provider’s office handles the prior authorization request; a reputable clinic will initiate this before your first scheduled injection and notify you of the outcome. Always confirm that prior auth was approved — do not assume it was processed automatically.
Get Help Understanding Gelsyn-3 Coverage
Join thousands of patients who've used our guides to navigate knee injection costs and insurance coverage.
Join 10,000+ readers. No spam.
Related Resources
- Knee Gel Injection Cost Guide: All Brands Compared
- Hyaluronic Acid Injections: Complete Treatment Guide
- Single Injection vs. Series: Which Is Right for You?
- Medicare Part B Coverage for Knee Injections
- Euflexxa Injection Cost Guide (2026)
- Orthovisc Injection Cost Guide (2026)
- HA Brands Guide 2026: All FDA-Approved Options
- Bird Allergy and Gel Injections: Your Safe Options
Last updated: April 2026. Pricing information reflects current market data and is subject to change. Medicare payment rates (ASP) are updated quarterly; always verify the current quarter’s rates at cms.gov. J7328 reimbursement figures above reflect recent CMS ASP Drug Pricing Files and are approximate.
Medical Disclaimer: This article is for educational purposes only and does not constitute medical or financial advice. Consult your healthcare provider to determine if Gelsyn-3 is appropriate for your condition, and contact your insurance plan directly to verify current coverage, prior authorization requirements, and your actual cost-share before scheduling treatment.
Topics
Enjoyed this article?
Get more insights like this delivered to your inbox weekly.
Join 10,000+ readers. No spam.